Vitamin D Level and Pain Type in Coccygodynia

NCT05047393 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2021-09-27

No results posted yet for this study

Summary

Coccygodynia is a painful clinical picture of the sacrococcygeal region.Pain in coccygodynia may be somatic, neuropathic or mixed. There are many studies that emphasize the relationship between vitamin D deficiency and pain.In this study, it is aimed to investigate the severity and type of pain, as well as the effect of vitamin D level on pain in patients with coccygodynia

Conditions

  • Coccyx Disorder
  • Neuropathic Pain
  • Nociceptive Pain
  • Vitamin D Deficiency

Interventions

OTHER

Current blood vitamin D level and painDetect questionairre score will be detected

PainDETECT neuropathic pain questionnaire will be used to evaluate the presence of nociceptive, mixed and neuropathic pain in patients. Patients with a total questionnaire score of 12 or less are considered nociceptive pain without a neuropathic pain component. If the total score is in the range of 13-18, the result is uncertain, but it is accepted that the neuropathic component can be found in the mixed type, and in the scores of 19 and above, it is accepted that the neuropathic pain component is present. Patients with previously obtained and finalized vitamin D levels \< 20 ng/mL, 20-30 ng/mL, and ˃30 ng/mL will be grouped as deficiency, insufficiency and normal, respectively.

Sponsors & Collaborators

  • Cumhuriyet University

    lead OTHER

Principal Investigators

  • Emel Güler, MD · Cumhuriyet University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05047393 on ClinicalTrials.gov